Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q3 2018 call → NOThe question asks whether management conveys that outsiders are currently underweighting something the company has already done, and whether management points to a concrete, already-completed or already-operating piece of the business whose contribution is still largely ahead of reported results. Let me analyze the transcript carefully. Key elements: 1. Does management indicate a recognition gap - that the way the company is seen/valued/measured doesn't match what it already is? 2. Does management point to a concrete, already-in-place thing whose payoff is still ahead? Let me look for these elements. Sean's comments: - "We are in a fortunate position as having continued customer and sales growth in our service territory" - "We've mentioned many times that a cornerstone of our strategy is to actively manage cost to customers, so new investments can be made to protect the customers bill. This is a prime example of this strategy in action. Since 2011, we've invested over $5 billion at the utility and customer bills have grown less than 1%." - "We are in a favorable position of having many options because of our healthy balance sheet, which provides significant financial flexibility." - "I do want to be very clear here that we will not sit on excess cash, nor will we allow the balance sheet to become lazy." - "We have a large backlog of projects that have not been reflected in our capital expenditure forecast. If the regulatory environment is constructive, you can expect to see increased investments that benefit customers. If not, cash will be deployed through dividends or other means to increase shareholder value." On the dividend: - "We announced our dividend policy back in 2014 with the formation of Enable and the flipping cash position from the midstream business. As investors, you rightfully inquire if we will continue with the increase and at what percentage. I can tell you this is an area where we are strongly focused." On the RFP for capacity needs: - "We issued an RFP for these capacity needs. We expect to make approval filing with the OCC in December and a similar filing in Arkansas. We have been impressed with the proposals and although we can't discuss the specifics. We are pleased that customers will see reduced cost as a result of our actions." On the grid modernization: - "We're under way in Arkansas.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.